Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is not yet recruiting. It focuses on depression and currently lists study information in Global.
In Global
This study is not yet recruiting. It focuses on schizophrenia and currently lists study information in Global.
In GlobalThis study is not yet recruiting. It focuses on depression and currently lists study information in China.
In Beijing
This study is not yet recruiting. It focuses on depression and currently lists study information in China.
In BeijingThis study is not yet recruiting. It focuses on depression and currently lists study information in Greece and Italy.
Multiple locations, including PátraiThis study is not yet recruiting. It focuses on depression and currently lists study information in Global.
In GlobalThis study is not yet recruiting. It focuses on depression and currently lists study information in Egypt.
In TantaThis study is not yet recruiting in the United States. It is testing accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment for schizophrenia.
Multiple locations, including BellflowerThis study is not yet recruiting. It focuses on anxiety and currently lists study information in Global.
In GlobalThis study is not yet recruiting. It focuses on depression and currently lists study information in China.
In Hong KongThis study is not yet recruiting in the United States. It focuses on depression.
In PittsburghThis study is not yet recruiting. It focuses on schizophrenia and currently lists study information in Global.
In GlobalHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.